Related Experiment Video
Updated: May 7, 2026
06:16
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
[Trust-based economics with medicine outcome-based pricing]
1Université Paris Descartes, 12, rue de l'École-de-Médecine, 75006 Paris, France; CEPS, ministère des affaires sociales et de la santé, 14, avenue Duquesne, 75350 Paris 07 SP, France.
Annales Pharmaceutiques Francaises
|October 1, 2013
Summary
Pharmaceutical industry trust is challenged by scandals and economic pressures. Performance agreements, linking drug reimbursement to real-world outcomes, offer a solution to restore confidence.
Area of Science:
- Pharmaceutical industry
- Health economics
- Drug development
Context:
- Declining public trust in the pharmaceutical sector due to scandals.
- Increased payer expectations for demonstrated clinical value and cost-effectiveness.
- Economic pressures demanding justification for high-cost medications.
Purpose:
- To explore a novel economic model for pharmaceutical market access.
- To address the challenge of value uncertainty and payer expectations.
- To propose a mechanism for restoring confidence in the pharmaceutical industry.
Summary:
- The pharmaceutical industry faces declining trust and heightened payer demands for proven value.
- A new market access model involves performance agreements for expensive drugs.
- Reimbursement is tied to real-world effectiveness, with refunds for failures.
Impact:
- Restores payer confidence through outcome-based agreements.
- Aligns drug value with patient benefit and economic realities.
- Promotes greater accountability and transparency in the pharmaceutical market.
Related Concept Videos
01:29Issues And Trends In Healthcare Delivery System
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
01:30Health Information Technology and Healthcare Information System
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:26Methods Of Healthcare Delivery System
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
01:22Ethics and Bioethics
Ethics is a philosophical study of moral actions. Ethics attempts to determine what is valuable for individuals and society. It examines the rational justification of moral judgments and analyzes what is morally just, fair, and right. Bioethics is a sub-discipline of applied ethics that analyzes the philosophical, social, and legal issues in life sciences and medicine. Ethical theories serve as a foundation for decision-making and represent the viewpoints from which people seek direction. They...